Latest Period
Q2 2026
Security Snapshot
Quantum Biopharma Ltd. - Class B Subordinate Voting Shares, no par value (QNTM) Institutional Ownership
CUSIP: 74764Y205
13F Institutional Holders and Ownership History from Q3 2024 to Q3 2026
Institutions Reporting
26
Shares (Excl. Options)
414,929
Price
$3.62
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class B Subordinate Voting Shares, no par value
- Symbol
- QNTM on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 414,929
- Total 13F value
- $1,502,643
- Portfolio coverage rank
- 0%
- Share change
- +160,647
- Value change
- +$567,376
- Number of holders
- 26
- Shares outstanding
- 8,088,444
- SEC-reported price per share
- $3.60
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- QNTM - Quantum Biopharma Ltd. - Class B Subordinate Voting Shares, no par value is tracked under CUSIP 74764Y205.
- 26 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 26 to 1 between Q2 2026 and Q3 2026.
- SEC-reported value moved from $1,502,643 to $3,600.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q2 2026.
Security key
74764Y205
Latest holder period
Q2 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
QNTM full holder history
Quantum Biopharma Ltd. SEC filings
Quantum Biopharma Ltd. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74764Y205:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
QNTM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 5% | -7.6% | $1,281,210 | +$629,805 | 400,378 | +97% | AdvisorShares Trust | 30 Sep 2026 |
| Malone Wealth Ventures LLC | 9.8% | -55% | $2,754,262 | -$3,327,659 | 375,752 | -55% | Malone Wealth Ventures LLC | 03 Feb 2026 |
As of 30 Jun 2026, 26 institutional investors reported holding 414,929 shares of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares, no par value (QNTM). This represents 5.1% of the company’s total 8,088,444 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 1,000 | $3,600 | $3.60 | 1 | |
| 2026 Q2 | 414,929 | $1,502,643 | +$567,376 | $3.62 | 26 |
| 2026 Q1 | 254,282 | $1,227,264 | +$573,005 | $4.83 | 24 |
| 2025 Q4 | 128,327 | $936,801 | +$435,810 | $7.30 | 23 |
| 2025 Q3 | 54,356 | $892,109 | -$1,115,491 | $16.40 | 16 |
| 2025 Q2 | 116,515 | $2,376,442 | +$1,109,790 | $20.25 | 17 |
| 2025 Q1 | 69,905 | $552,699 | -$2,591 | $7.71 | 13 |
| 2024 Q4 | 69,772 | $256,361 | +$72,515 | $3.67 | 9 |
| 2024 Q3 | 47,959 | $191,956 | +$191,956 | $4.00 | 11 |